A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
about
Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review.What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial
P2860
A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase II study of concurrent ...... hageal squamous cell carcinoma
@en
A phase II study of concurrent ...... ageal squamous cell carcinoma.
@nl
type
label
A phase II study of concurrent ...... hageal squamous cell carcinoma
@en
A phase II study of concurrent ...... ageal squamous cell carcinoma.
@nl
prefLabel
A phase II study of concurrent ...... hageal squamous cell carcinoma
@en
A phase II study of concurrent ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
A phase II study of concurrent ...... hageal squamous cell carcinoma
@en
P2093
Chuanhua Zhao
Feijiao Ge
Jianming Xu
Jianzhi Liu
Rongrui Liu
Yuling Chen
P2860
P304
57310-57316
P356
10.18632/ONCOTARGET.9809
P407
P577
2016-08-01T00:00:00Z